Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 50S ribosomal subunit peptidyl transferase center (PTC) is the catalytic core of the ribosome, responsible for synthesizing proteins by facilitating peptide bond formation (Steitz & Moore, 2003). Located within the 23S ribosomal RNA, the PTC acts as a ribozyme that correctly orients the aminoacyl-tRNA and peptidyl-tRNA substrates to allow for the nucleophilic attack necessary for polypeptide elongation. Because protein synthesis is vital for bacterial growth, the PTC is a major target for several classes of antibiotics, including oxazolidinones, lincosamides, and pleuromutilins (Polikanov et al., 2014). These drugs bind to the PTC to physically obstruct the binding of tRNA or the movement of the growing peptide chain through the exit tunnel. However, the structural similarity between bacterial and human mitochondrial ribosomes can lead to clinical safety concerns, such as myelosuppression, due to off-target inhibition of mitochondrial translation (Leach et al., 2007). Additionally, the clinical utility of PTC-targeting drugs is frequently challenged by the emergence of resistance mechanisms, such as rRNA mutations or the acquisition of the cfr methyltransferase gene (Long et al., 2006).
Inhibition of bacterial protein synthesis by binding to the peptidyl transferase center (PTC) of the 50S ribosomal subunit, which prevents the formation of peptide bonds or sterically blocks the nascent peptide exit tunnel (Wilson, 2014).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 50S ribosomal subunit peptidyl transferase center (PTC).